Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573729 · ClinicalTrials.gov registry record · Phase 1
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
A Phase 1 study of Port Wine Stains, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00573729 is a Phase 1 study of Port Wine Stains that has completed, run by University of California, Irvine. The registered enrollment target is 56 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00573729, a Phase 1 study of Port Wine Stains, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
Port wine stain are a congenital, progressive vascular malformation of human skin. The pulsed dye laser is approved by the Food and Drug Administration for the treatment of choice. However, the degree of port wine stain blanching seen following pulsed dye laser treatment remains variable and unpredictable. If the ultimate standard required is complete lesion blanching, the average success rate is below 10%, even after undergoing numerous pulsed dye laser treatments. Moreover, less than 50% of patients achieve 50% fading of their Port wine stain in response to pulsed dye laser therapy.
Conditions Studied
Interventions
- OTHER Pulsed Dye Laser 577 nm
- OTHER Pulsed Dye Laser 595 nm
Study Locations (1)
California
- Beckman Laser Institute,University of California,Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573729
The ClinicalTrials.gov registry entry for NCT00573729 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Port Wine Stains appearing as the primary indexed condition, and to 2 interventions - of which Pulsed Dye Laser 577 nm is the first listed.
NCT00573729 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00573729 about?
NCT00573729 is a clinical study titled "Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths". Port wine stain are a congenital, progressive vascular malformation of human skin. The pulsed dye laser is approved by the Food and Drug Administration for the treatment of choice. However, the degree of port wine stain blanching seen following pulsed dye laser treatment remains variable and unpredi...
What is the current status of trial NCT00573729?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2007-03. Estimated completion is 2009-01.
What conditions does trial NCT00573729 study?
This clinical trial studies the following conditions: Port Wine Stains.
What interventions are being tested in trial NCT00573729?
The interventions under investigation include: Pulsed Dye Laser 577 nm (OTHER), Pulsed Dye Laser 595 nm (OTHER).
Who is sponsoring clinical trial NCT00573729?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00573729 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.